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Introduction
 In the last three decades, the incidence of breast 
cancer has increased and now it is one of the most 
common cancers in females worldwide, particularly in 
Iran (Brennan and Houssami, 2011). It is one of the main 
reasons of cancer-related mortality in women and its rate in 
developing countries is annually 70% of which will occur 
(Haghighat S, 2012). Researchers believe that mental and 
physiological conditions of individuals are important in 
the promotion and development of cancers and changes 
in patient’s life style could be effective in incidence of 
stress (Elenkov et al., 2000; Cohen et al., 2007; Barik et 
al., 2013). Improvement the quality of life can be effective 
in reduction of breast cancer patients’ distress and the risk 
of breast cancer (Yavuzsen, 2012).
 In addition, the occurrence of different types of cancers 
including breast cancer could be associated with chronic 
stress (Marsh et al., 2010). Chronic stress has an important 
role in evidence of cancers specially breast cancer and 
cause to secretion of neurotransmitters. Numerous studies 
showed the role of neurotransmitters in the occurrence 
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Abstract
 Breast cancer is the most common cancer among females worldwide and a most prevalent malignancy in 
Iranian women. Chronic stress may make an important contribution to cancer, especially in the breast. Numerous 
studies showed roles of neurotransmitters in the occurrence and progression of cancers which are mediated by 
their various types of receptors. This study was conducted to evaluate alterations in the expression profile of 
dopamine receptor genes in peripheral blood mononuclear cells (PBMC) as stress factors in breast cancer patients 
and the human breast cancer cell line (MCF-7). Peripheral blood samples were obtained from 30 patients and 
30 healthy individuals. Total mRNA was extracted from PBMC and MCF-7 cells and RT-PCR was performed 
to confirm the presence of five dopamine receptors (DRD1-DRD5). Expression changes of dopamine receptor 
genes were evaluated by real time PCR. We observed that DRD2-DRD4 in PBMCs of breast cancer patients 
were increased compared to healthy individuals. In addition, all dopamine receptor subtypes but DRD1 were 
expressed in MCF-7 cells. Therefore, alterations of these receptors as stress factorsshould be assessed for selecting 
appropriate drugs such as D2-like agonists for treatment of breast cancer after performing complimentary tests. 
Determining the expression profile of dopamine receptor genes thus seems promising.
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and progression of cancers which is mediated by their 
various types of receptors (Elenkov et al., 2000; Marsh 
et al., 2010; Mancino et al., 2011). In general, the nerve 
fibers are interconnected with lymphatic and blood vessels 
(Elenkov et al., 2000). Recently, several studies have 
shown that different mediators of the nervous system 
like neurotransmitters have an important role in immune 
system functions, lymphocyte migration and tumor 
angiogenesis, lymphogenesis and progression. Several 
neurotransmitters may lead to tumor progression via 
stimulating the migration and dissemination of tumor 
cells to distant sites (Mancino et al., 2011; Hejazi et al., 
2014).     
 One of these neurotransmitters is dopamine which has 
proliferative effects in non-transformed cells (Mancino et 
al., 2011). Whereas, some of neurotransmitters particularly 
dopamine can inhibit the T cell receptor (TCR)-induced 
cell proliferation and stimulation of T cells to secretion 
of cytokines and consequently leads immune system 
depletion (Basu et al., 2010). Dopamine affects different 
types of cells via its various receptors. These receptors 
are from G-protein family containing D1and D2 family 
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receptors. Both D1 and D5 receptors are members of 
D1-like family that play a role as stimulator and induce 
increases intracellular cyclic AMP (cAMP). In contrast, 
D2 and D4 receptors, members of D2-like receptor family, 
inhibit intracellular cAMP on stimulation (Beaulieu and 
Gainetdinov, 2011). 
 Different studies showed that these receptor genes 
expression profiles were changed associated with chronic 
stress condition in various types of diseases including 
lupus erythematosus, schizophrenia and non-small lung 
cancer (Kwak et al., 2001; Shaikhpoor et al., 2012; 
Jafari et al., 2013). Whereas, regarding to the importance 
of dopamine receptors gene expression changes in 
pathogenesis of diseases related to chronic stress, in breast 
cancer patients has not been reported yet. It is assumed that 
the stress can be conducted to alterations in expression of 
dopamine receptor genes in some diseases which could 
be attributed to development of the disease. Therefore, 
we hypothesized that change in the expression level of 
dopamine receptor genes (DRD1-DRD5) in the PBMCs 
as well as a human breast cancer could be a stress factors 
in breast cancer.
Materials and Methods
Patient’s sample
The naive patients group consisted of 30 breast cancer 
patients with the mean age of 34 years (ranged from 20 to 
40 years) who were referred to Shohada hospitals, Tehran, 
Iran, were enrolled. All of the cases had a chronic stress 
or a life event in their background. The control group 
included 30 individuals and the average of 35years old 
(ranged from 20 to 40 years). Patient consent for all of 
samples was obtained according to the Declaration of 
Helsinki principles. The pathological information of all 
patients was obtained from Pathology Department of 
this academic Hospital. Also, thirty healthy individuals 
were included as controls. Exclusion and inclusion 
criteria were determined according to the revised criteria 
for classification of breast cancer patients, published by 
cancer research center of Iran, and demographic data of the 
studied patients, were collected from cancer department 
of Shohada hospital. This project was approved by 
the National Institute for Genetic Engineering and 
Biotechnology (NIGEB) and written informed consent 
was obtained from all participants of this study.
Cell isolation
Peripheral blood samples (5ml) were obtained from 
the cubical vein and were collected in cell preparation 
tubes containing an anticoagulant (0.05 M EDTA). 
Blood samples were then diluted with an equal volume of 
PBS. Peripheral blood mononuclear cells (PBMC) were 
isolated from 4ml of each blood sample by Ficoll-Hypaque 
(Pharmacia, Uppsala, Sweden) density centrifugation. 
Cell density and osmolity were 1.077±0.001 g/ml (20˚C) 
and 290±15 moms, respectively. Horizontal swing-out 
centrifuge was used for cell isolation in 2500 rpm, for 
20 minutes and 1.0 speed regulation. The Buffy coat 
(lymphocyte layer) was collected and centrifuged in 1600 
RPM, for 10 minutes and 2.0 Speed regulations. Finally, 
the resulting pellet was washed in Phosphate buffer saline 
(PBS) (Hejazi et al., 2014).
Cell culture
Media, serum and MCF-7 cell line were provided 
from Gibco (Germany) and Pasture institute of Iran. The 
cells were cultured in DMEM supplemented with 10 
percent fetal bovine serum. To evaluate gene expression 
of dopamine receptors, 1×106 of MCF-7 cells were used 
for RNA extraction.
RT-PCR
The total mRNA was isolated from PBMC by High 
pure RNA isolation Kit (Roche, Germany), according 
to the manufacturer’s instructions. The RNA extracted 
samples read with Nanodrop to measuring the RNA 
concentration in samples and in this stage we synchronize 
all other samples. The RNA (1μg) from each sample was 
used to synthesize first-strand cDNA and cDNA synthesis 
was carried out by cDNA synthesis kit (Fermentase, 
Germany). Similarly, cDNA synthesis was performed 
based on manufacture’s protocols. Primer design was 
carried out using oligo5 software. Primer specificity was 
theoretically checked by BLAST database search against 
nucleotide reference NCBI database and experimentally 
verified by the positive control amplification. To confirm 
the presence of dopamine receptor genes in blood and 
MCF-7 cells, a common PCR technique was carried out for 
all subtypes (DRD1-DRD5). Reaction mixtures contained 
2-2.5 mM MgCl2, 0.5 mM each of the dNTPs, 0.8 -1mM 
primers, 2.5µLTaq DNA polymerase (Sinagene), and 1 
µL of the cDNA was used as template in each RT-PCR 
reaction. In order to amplify the DRD1-DRD5 and b-actin 
genes, PCR was initiated at 95°C for 5min and amplified 
during 35 cycles at 95°C for 1min, 56, 60, 62, 58, 58 and 
62°C for40 s and 72°C for 1 min and followed by a final 
extension step at 72 for 10 min. Finally, the PCR products 
were visualized by gel electrophoresis on a 2% agarose 
gel. The primers for DRD1-DRD5 receptor genes, and 
b-actin gene as housekeeping gene were designed based 
on GenBank sequences (Table 1). 
Real time PCR
Reactions were also carried out in a Real Time-
PCR (Corbett, Germany) with a Cyber green flourgenic 
nucleotide to monitor cDNA amplification by (Roche 
kit, Germany) measuring the increase in Fluorescence 
intensity and using primer pairs specific for five 
dopamine receptors (DRD1-DRD5) mRNAs and β-actin 
as the internal control. The PCR was performed in 10 
µL of solution, consisting of 2 µL of Fast Start Master 
solution and 0.3 µM of each primer. A total of 9 µL of 
this reaction mix was placed into 0.1 vials, and 1 µL 
of cDNA was added as a template. Thermal cycling 
consisted of an initial denaturation step 95°C for min 
followed by an amplification program (primer annealing, 
amplification and quantification) repeated for 45 cycles. 
The amplification program was 95°C for 10 sec, 56, 60, 
62, 58, 58 and 62°C for 10 sec, respectively for DRD1 
to DRD5 and 72°C for 10 sec with a single fluorescence 
acquisition at the end of the elongation step. The third 
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segment consisted of a melting curve program performed 
by default program of the real time-PCR instrument. 
Melting curve analysis showed only one peak for each 
reaction and this also confirmed by electrophoresis of PCR 
products that showed only one band of the expected size.
Sequencing
Receptors and β-actin fragments were sequenced by 
DNA sequencer ABI 3700 capillary system (Applied Bio 
System, USA) to confirm amplified sequences.
Statistical analysis
The number of samples was determined by Minitab 
16.1 software and efficiency of each reaction was precisely 
evaluated by Linreg software. Real time PCR data were 
analyzed by Rest 2005 and 2009 software. The correlation 
between the changes in dopamine receptor gene expression 
and the items such as age of patients, stages of the disease, 
Progesterone receptor (PR),human epidermal growth 
factor Receptor (HER-2) and estrogen receptor (ER) gene 
expression was assessed by SPSS software (version 16.0). 
In the current study, the p-value less than0.05 (P< 0.05) 
was considered statistically significant.
Results 
Pathologic analysis
Pathology examinations were showed that 30, 23, 37 
and 10 percent of the patients respectively were related to 
stages of I, II, III, and IV. Almost 75 percent of patients 
expressed ER and 67 percent of them expressed PR. 
Also, 40 percent of patients were HER-2 positive. Six 
percent of patients had a mutation in P53 protein. In this 
study, expression of different types of dopamine receptors 
genes were evaluated in PBMC breast cancer patients 
and healthy individuals PBMC and also in human breast 
cancer cell line (MCF-7). 
PBMC expresses in breast cancer
The results of RT-PCR showed that all types of 
dopamine receptors were expressed in PBMC of breast 
cancer and healthy individuals (Figure1).We also evaluated 
gene expression of dopamine receptors in human breast 
cancer cells (MCF7).The results of RT-PCR revealed that 
all dopamine receptor subtypes (DRD2-DRD5), expressed 
on MCF-7 cell line. However, dopamine receptor gene 
(DRD1) was not detected on electrophoresis gel (Figure2).
Expression analysis
Analysis of Real time-PCR revealed there were 
considerable differences in gene expression rates between 
patients and healthy controls. DRD1, DRD2, DRD3 and 
DRD4 genes in PBMC of breast cancer cases showed a 
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Table 1. Primer sequences used in RT-PCR and Real time -PCR
Locus Primers Accession number(Gene Bank) Size
β-actin- F 5’-AGACGCAGGATGGCATGGG-3’  
β-actin -R 5’-GAGACCTTCAACACCCCAGCC-3’ NM_001101.3 161bp
DRD1-F 5’- CTTCCTCAACGTTTCGGAGCC-3’  
DRD1-R 5’- AGCTCTCCAAACGCCTTGCCTT-3’ NM_000794.3 115bp
DRD2-F 5’- TGTACAATACGCGCTACAGCTCCA-3’  
DRD2-R 5’- ATGCACTCGTTCTGGTCTGCGTTA-3’ NM_016574.3 127bp
DRD3-F 5’- TCTGTGCCATCAGCATAGACAGGT-3’  
DRD3-R 5’-TAAAGCCAAACAGAAGAGGGCAGG-3’ NM_000796.3 156bp
DRD4-F 5’- TCTTCGTCTACTCCGAGGTCCA-3’  
DRD4-R 5’- TGATGGCGCACAGGTTGAAGAT-3’ NM_000797.3 100bp
DRD5-F 5’-TCATCTATGCCTTCAACGCCGACT-3’  
DRD5-R 5’-  AGCTGCGATTTCCTTGTGGAAGAC-3’ NM_000798.4 155bp
Figure 1. S ow All Types of Dopamine Receptors have 
been Expressed in PBMCs Cells. Lane M: Molecular 
size marker 100bp (Fermentase, Germany), Lane1: control 
negative of DRD1-115bp, Lane2:DRD1-115bp, lane3: DRD2-
127bp, Lane4: DRD3-156bp, Lane5: DRD4-100bp and Lane6: 
DRD5-155bp
Figure 2. Show all types of dopamine receptors have 
been expressed in MCF-7 cells except DRD1. Lane M: 
Molecular size marker 100bp (Fermentase, Germany), Lane1: 
DRD1-115bp, Lane2: DRD2-127bp, Lane3: DRD3-156bp, 
Lane4: DRD4-100bp and Lane5: DRD5-155bp
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significant over expression compared to their counterparts 
in healthy individuals. (Table 2). Furthermore, all 
sequenced fragments were checked by BLAST database 
against nucleotide reference NCBI database and confirmed 
amplicon sequences. Investigation of the association of 
dopamine receptor gene expression with factors such as 
patient’s age, stage of the disease, and the expression of 
ER, PR and HER2 genes showed a significantly higher 
expression of DRD2 gene in all stages of breast cancer. 
One way Anova analysis confirmed the significant 
association between over expression of DRD2 gene 
with the progression of the disease (P-value≤ 0.004). 
Over expressions of dopamine receptor genes were not 
associated with patient’s age or expression of ER, PR and 
HER-2 genes.
Discussion
Based on our hypothesize, the results show difference 
of dopamine gene expression profile in PBMCs as well as 
a human breast cancer cell line (MCF-7) as stress factors 
in  breast cancer patients. Previous study demonstrated 
that mental and physiological conditions of individuals are 
important in the promotion and development of cancers 
and changes in patient’s life style could be effective in 
incidence of stress (Cohen et al., 2007; Mancino et al., 
2011; Barik et al., 2013). Cancer cells and nerve fibers 
have cross-talks and thus could influence on each other. 
Cancer cells cover up to 33% of the surrounding space 
of perineural cells and secret soluble factors which lead 
to perineural cell invasion (Sarkar et al., 2008; De Leeuw 
van Weenen et al., 2011). Moreover, different signaling 
pathways are shared by cancer cells whose presence is 
important for successful axon growth and elongation 
towards its target region. For example, serine/threonine 
specific protein kinase (Akt) and phosphoglycogen 
synthase kinase 3 (Gsk3) pathways are important for 
neuronal polarity and microtubule stability (Tonge et 
al., 1998). Several neurotransmitters have been found 
to be related to tumor progression via activation of 
signaling pathways linked to cell proliferation and 
survival, including Phosphatidylinositide 3-kinases 
(PI3K), Mitogen-activated protein kinases (MAPK) and 
Akt pathways (Beaulieu and Gainetdinov, 2011). These 
types of events occur due to secretion of catecholamines 
(stress-mediators) which increases in response to stressful 
events (Ganguly, 2010; Beaulieu and Gainetdinov, 
2011). Most of catecholamines including epinephrine 
and norepinephrine are related to carcinogenesis and 
tumor progression (Mancino et al., 2011). In addition, 
there is a close relationship between immune and 
nervous systems. They interact with each other through 
cytokines, neurotransmitters, hormones and neuropeptides. 
Neurotransmitters are mediators that have traditionally 
been regarded as signal substance.  Various studies have 
shown that neurotransmitters, including dopamine and 
serotonin affected immune cells in a number of diseases 
through their receptors (Reiche et al., 2004; Ganguly 
S, 2010). Dopamine receptors activity is mediated by 
G-proteins. There are five different subtypes for dopamine 
receptors (DRD1-DRD5) which are classified into two 
families including D1-like family (stimulatory receptors) 
and D2-like family (inhibitory receptors) (Kirillova et 
al., 2008; Beaulieu and Gainetdinov, 2011). Prior studies 
reported that in different diseases the gene expression 
of dopamine receptors have been altered in immune 
and nervous systems (Kwak et al., 2001; Jafari et al., 
2013). For instance, significant decreasing in D2-D4 
were reported in PBMCs of non-small cell long cancer 
(Shaikhpoor et al., 2012). Kwak et al (2001) were reported 
significant elevation in the expression level of D2 and D3 
genes in schizophrenia (Kwak et al., 2001). In arthritis 
rheumatoid, the expression of D2 was decreased and D4 
was elevated, respectively. Jafari et al (2013) indicated 
an over expression of D4 in lupus erythromatosus (Jafari 
et al., 2013). In the current study, expression rates of 
DRD2-DRD4 genes have been observed to be significantly 
higher in PBMC of breast cancer patients than healthy 
controls and also the expression of DRD2 increased with 
promoting the stages of disease. These alterations could 
lead to changes in the amount of T-cells which play a 
key role in both cellular and hemoral immune systems 
(Elenkov et al., 2000). T-cells control the natural tumor 
cells via secretion of cytokines TNF-α (Jiang et al., 2007). 
Thus, the coordinated over expression of DRD2 family 
receptor genes enhances each other (additive effect) and 
leads to reduction of T-cells amount. Therefore, it may be 
a result for decreasing of anti-tumor cell cytokines and 
subsequently tumor progression may be occurred. We also 
observed the expression of DRD2 to DRD5 genes in MCF-
7 cells. However, DRD1 gene expression was not detected 
in this cell line. It might be as a result of the inhibitory 
effect of dopamine in breast cancer cells. As Sarker et al 
(2008) had previously suggested that dopamine have an 
inhibitory effect in the cells of breast cancer bearing- mice 
(Sarkar et al., 2008). Other studies had also disclosed an 
inhibitory role for dopamine, D2-agonists and antagonists 
in several types of cancers including bone marrow (HL-
60), gastric and colon cancers cells (Inayat-Hussain et 
al., 2000; Chakroborty et al., 2004; Sarkar et al., 2008).
In conclusion, recent investigations give an idea 
about DRD2 gene expression changes as stress factor 
along with other diagnostic markers could be used as a 
reliable marker attributed to development of breast cancer. 
However, further investigations using D2-agonist as a new 
therapeutic agent are recommended.
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